Featured Article: Depletion of HDL3high density lipoprotein and altered functionality of HDL2in blood from sickle cell patients
Authors:
- 24 April 2017
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 242 (12) , 1244-1253
Abstract
In sickle cell disease (SCD), alterations of cholesterol metabolism is in part related to abnormal levels and activity of plasma proteins such as lecithin cholesterol acyltransferase (LCAT), and apolipoprotein A-I (ApoA-I). In addition, the size distribution of ApoA-I high density lipoproteins (HDL) differs from normal blood. The ratio of the amount of HDL2particle relative to the smaller higher density pre-β HDL (HDL3) particle was shifted toward HDL2. This lipoprotein imbalance is exacerbated during acute vaso-occlusive episodes (VOE) as the relative levels of HDL3decrease. HDL3deficiency in SCD plasma was found to relate to a slower ApoA-I exchange rate, which suggests an impaired ABCA1-mediated cholesterol efflux in SCD. HDL2isolated from SCD plasma displayed an antioxidant capacity normally associated with HDL3, providing evidence for a change in function of HDL2in SCD as compared to HDL2in normal plasma. Although SCD plasma is depleted in HDL3, this altered capacity of HDL2could account for the lack of difference in pro-inflammatory HDL levels in SCD as compared to normal. Exposure of human umbilical vein endothelial cells to HDL2isolated from SCD plasma resulted in higher mRNA levels of the acute phase protein long pentraxin 3 (PTX3) as compared to incubation with HDL2from control plasma. Addition of the heme-scavenger hemopexin protein prevented increased expression of PTX3 in sickle HDL2-treated cells. These findings suggest that ApoA-I lipoprotein composition and functions are altered in SCD plasma, and that whole blood transfusion may be considered as a blood replacement therapy in SCD.Impact statement: Our study adds to the growing evidence that the dysfunctional red blood cell (RBC) in sickle cell disease (SCD) affects the plasma environment, which contributes significantly in the vasculopathy that defines the disease. Remodeling of anti-inflammatory high density lipoprotein (HDL) to pro-inflammatory entities can occur during the acute phase response. SCD plasma is depleted of the pre-β particle (HDL3), which is essential for stimulation of reverse cholesterol from macrophages, and the function of the larger HDL2particle is altered. These dysfunctions are exacerbated during vaso-occlusive episodes. Interaction of lipoproteins with endothelium increases formation of inflammatory mediators, a process counteracted by the heme-scavenger hemopexin. This links hemolysis to lipoprotein-mediated inflammation in SCD, and hemopexin treatment could be considered. The use of RBC concentrates in transfusion therapy of SCD patients underestimates the importance of the dysfunctional plasma compartment, and transfusion of whole blood or plasma may be warranted.Keywords
This publication has 65 references indexed in Scilit:
- A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferaseAnalytical Biochemistry, 2013
- HDL-apoA-I Exchange: Rapid Detection and Association with AtherosclerosisPLOS ONE, 2013
- Plasma HDL Reduces Nonesterified Fatty Acid Hydroperoxides Originating from Oxidized LDL: a Mechanism for Its Antioxidant AbilityLipids, 2013
- Lipid levels in sickle‐cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertensionBritish Journal of Haematology, 2010
- Abnormal function of high‐density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritisArthritis & Rheumatism, 2009
- Characterization of Whole Blood Gene Expression Profiles as a Sequel to Globin mRNA Reduction in Patients with Sickle Cell DiseasePLOS ONE, 2009
- Hemoglobin and Its Scavenger Protein Haptoglobin Associate with ApoA-1-containing Particles and Influence the Inflammatory Properties and Function of High Density LipoproteinJournal of Biological Chemistry, 2009
- Oxidized phospholipids in control of inflammation and endothelial barrierTranslational Research, 2009
- Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell diseaseBlood, 2009
- The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest painThrombosis and Haemostasis, 2009